| Robert Paul Holman, MD | |
|
1635 N George Mason Dr, Suite 180, Arlington, VA 22205-3601 | |
| (703) 276-7798 | |
| (703) 276-0433 |
| Full Name | Robert Paul Holman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 1635 N George Mason Dr, Arlington, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023026895 | NPI | - | NPPES |
| 006055079 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 0101038151 (Virginia) | Primary |
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
In 2010, after allegations of fraud among some fund recipients in several countries, the Global Fund to Fight AIDS, Tuberculosis and Malaria convened "an independent, high-level panel to review its financial controls and how grant money is spent," and the Fund "is now implementing the panel's recommendations," PlusNews reports.
The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
Soligenix, Inc., a late-stage biotechnology company, announced today that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.
Researchers at the University of Virginia School of Medicine have reversed depression symptoms in mice by feeding them Lactobacillus, a probiotic bacteria found in live-cultures yogurt.
› Verified 9 days ago
| Entity Name | Unity Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093894172 PECOS PAC ID: 3476647264 Enrollment ID: O20071024000456 |
News Archive
In 2010, after allegations of fraud among some fund recipients in several countries, the Global Fund to Fight AIDS, Tuberculosis and Malaria convened "an independent, high-level panel to review its financial controls and how grant money is spent," and the Fund "is now implementing the panel's recommendations," PlusNews reports.
The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
Soligenix, Inc., a late-stage biotechnology company, announced today that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.
Researchers at the University of Virginia School of Medicine have reversed depression symptoms in mice by feeding them Lactobacillus, a probiotic bacteria found in live-cultures yogurt.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Paul Holman, MD 1635 N George Mason Dr, Suite 180, Arlington, VA 22205-3601 Ph: (703) 276-7798 | Robert Paul Holman, MD 1635 N George Mason Dr, Suite 180, Arlington, VA 22205-3601 Ph: (703) 276-7798 |
News Archive
In 2010, after allegations of fraud among some fund recipients in several countries, the Global Fund to Fight AIDS, Tuberculosis and Malaria convened "an independent, high-level panel to review its financial controls and how grant money is spent," and the Fund "is now implementing the panel's recommendations," PlusNews reports.
The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
Soligenix, Inc., a late-stage biotechnology company, announced today that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.
Researchers at the University of Virginia School of Medicine have reversed depression symptoms in mice by feeding them Lactobacillus, a probiotic bacteria found in live-cultures yogurt.
› Verified 9 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Dr. Irmindra S Rana, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |